Summary BioVendor - Laboratorni Medicina as (BioVendor) is a developer and manufacturer of immunoassays, recombinant protiens, antibodies and endotoxin-removal products.The company provides products such as immunoassays, proteins, antibodies, endotoxin removal products, endotoxin detection products, immuno-histochemistry, cell-based assays and colorimetric assays, among others.
Its products are used in animal studies, apoptosis, asthma and allergic rhinitis, atherosclerosis, autoimmunity, blood pressure regulation and no metabolism, bone and cartilage metabolism, cardiovascular disease, cell adhesion proteins and research applications, among others.BioVendor markets its products through a network of distributors in Andorra, Belgium, Cyprus, Denmark, Finland, France, Greece, Greenland, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, the Netherlands, Norway, Portugal, Spain, Sweden, the Czech Republic and the UK, among others.
BioVendor is headquartered in Brno, the Czech Republic.
BioVendor - Laboratorni Medicina as - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
The Global Antibody Partnering Terms and Agreements 2014 to 2021 report provides comprehensive understanding and unprecedented access to the Antibody partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies...
This report is 90% complete and will include the latest impact analysis of Covid-19 along with updated quarterly market data for the year 2021 (estimated). This report will be delivered within three working days post order confirmation. Global Pharmacovigilance Market, By Clinical Trial Phase (Pre-Clinical, Phase 1,...
The healthcare analytical testing services market is projected to reach USD 9.8 billion by 2026 from USD 5.6 billion in 2021, at a CAGR of 11.9%. Growth in the market is driven by the rising trend of outsourcing of analytical testing by pharmaceutical companies and medical device companies, an increasing number of clinical trials, and the...
Interventional Cardiology Devices Market was valued at USD 13.11 billion in 2020, and is projected to reach a value of USD 20.07 billion by 2026, is expected to grow annually by 7.48% CAGR 2021-2026. The Interventional Cardiology Devices market is anticipated to have significantly impacted by the outbreak of the COVID-19 pandemic...
The global particle size analysis market size is projected to reach USD 492 million by 2026 from USD 371 million in 2021, growing at a CAGR of 5.8%. The growth of the market is attributed to increasing research activities in the field of nanotechnology, growing investments in pharmaceutical R&D, and stringent regulatory guidelines for product...
120 pages •
By Infiniti Research Limited
• Nov 2021
Global Industrial Cleaning Chemicals Market 2021-2025 The analyst has been monitoring the industrial cleaning chemicals market and it is poised to grow by $ 11.77 bn during 2021-2025, progressing at a CAGR of 4.49% during the forecast period. Our report on the industrial cleaning chemicals market provides a holistic analysis,...
The global endocrine testing market reached a value of US$ 10 Billion in 2020. Looking forward, the analyst expects the market to grow at a CAGR of 8.7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic...
The global chondroitin sulfate market grew at a CAGR of around 4% during 2015-2020. Chondroitin sulfate (CS) is a water-soluble polymer comprising alternating N-Acetylgalactosamine and glucuronic acid, which is naturally found in the cartilage, bone and cornea of animals. CS (C6H13NO5) is anti-atherogenic, inflammatory,...
The global neurorehabilitation devices market exhibited strong growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 12% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...
59 pages •
By Euromonitor International
• Nov 2021
? The COVID-19 pandemic continued to have a mixed impact on sales across consumer health in 2021. Many OTC categories saw higher demand as they were used to treat the symptoms of the COVID-19 virus as well as side-effects of the vaccine, while some herbal/traditional categories saw higher demand as consumers looked to improve their overall...
Analgesic Medicine Sales
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.